These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial. Jeevanandam V; Barr ML; Auteri JS; Sanchez JA; Fong J; Schenkel FA; Marboe CC; Michler RE; Smith CR; Rose EA J Thorac Cardiovasc Surg; 1992 Feb; 103(2):194-8; discussion 198-9. PubMed ID: 1735983 [TBL] [Abstract][Full Text] [Related]
3. A comparison of intracellular solutions for donor heart preservation. Hendry PJ; Labow RS; Keon WJ J Thorac Cardiovasc Surg; 1993 Apr; 105(4):667-73. PubMed ID: 8469000 [TBL] [Abstract][Full Text] [Related]
4. Incomplete recovery of working heart function after twenty-four-hour preservation with a modified University of Wisconsin solution. Smolens IA; Follette DM; Berkoff HA; Castellanos LM; Segel LD J Heart Lung Transplant; 1995; 14(5):906-15. PubMed ID: 8800727 [TBL] [Abstract][Full Text] [Related]
5. Analysis of myocardial function in orthotopic cardiac allografts after prolonged storage in UW solution. Elbeery JR; Lucke JC; Speier R; Rankin JS; VanTrigt P J Heart Lung Transplant; 1991; 10(4):527-36. PubMed ID: 1911795 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of hypothermic heart preservation with University of Wisconsin solution in heterotopically and orthotopically transplanted canine hearts. Mori Y; Hirose H; Murakawa S; Yamada T; Ishikawa M J Heart Lung Transplant; 1994; 13(4):688-950. PubMed ID: 7947886 [TBL] [Abstract][Full Text] [Related]
7. Effects of calcium concentration, lactobionate content, and sodium/ potassium ratio of preservation solutions on resting left ventricular pressure and postreperfusion function of rabbit heterotopic heart transplants. Termignon JL; Pradier F; Petit A; Journois D; Weiss M; Mazmanian M J Heart Lung Transplant; 1995; 14(6 Pt 1):1126-35. PubMed ID: 8719460 [TBL] [Abstract][Full Text] [Related]
8. Impact of University of Wisconsin solution on clinical heart transplantation. A comparison with Stanford solution for extended preservation. Stringham JC; Love RB; Welter D; Canver CC; Mentzer RM Circulation; 1998 Nov; 98(19 Suppl):II157-61; discussion II162. PubMed ID: 9852898 [TBL] [Abstract][Full Text] [Related]
12. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. Wheeldon DR; Potter CD; Oduro A; Wallwork J; Large SR J Heart Lung Transplant; 1995; 14(4):734-42. PubMed ID: 7578183 [TBL] [Abstract][Full Text] [Related]
13. The effects of Ca++ on the preservation of myocardial energy and function with University of Wisconsin solution. A 31P nuclear magnetic resonance study of isolated blood perfused Langendorff pig hearts. Tian G; Biro GP; Butler KW; Xiang B; Vu C; Deslauriers R J Heart Lung Transplant; 1993; 12(1 Pt 1):81-8. PubMed ID: 8443206 [TBL] [Abstract][Full Text] [Related]
14. Pretreatment of donors with endothelin receptor antagonist TAK-044 improves cardiac functional recovery following preservation with University of Wisconsin solution. Kaneda T; Zhang ZW; Ogawa T; Otaki M; Saga T Scand Cardiovasc J; 2002 Mar; 36(2):105-7. PubMed ID: 12028874 [TBL] [Abstract][Full Text] [Related]
15. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation. Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584 [TBL] [Abstract][Full Text] [Related]